Abstract
The idea of applying reactive oligonucleotide derivatives on nucleic acids (NA) for the purpose of achieving specific reactive effects was already suggested more than 30 years ago (Belikova et al. 1967). Since then, various oligonucleotide derivatives have been created which are capable of damaging nucleic acids and thereby influencing their function (Knorre et al. 1994). However, such oligonucleotide conjugates have not yet been applied as artificial nucleases in either scientific or medical practice. A number of drawbacks hampering a wide application of these oligonucleotide derivatives have been revealed and not yet overcome. One of these drawbacks is insufficient interaction efficiency with a target NA; another, a low selectivity of this interaction.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
van Atta RB, Bernadou J, Meunier B, Hecht SM (1990) On the chemical nature of DNA and RNA modification by a hemin model system. Biochemistry 29:4783–4789
Belikova AM, Zarytova VF, Grineva NI (1967) Synthesis of ribonucleosides and diribonucleoside phosphates containing 2-chloroethylamine and nitrogen mustard residues. Tetrahedron Lett 8:3557–3562
Buettner GR, Moseley PL (1992) Ascorbate both activates and inactivates bleomycin by free radical generation. Biochemistry 31:9784–9788
Burger RM (1998) Cleavage of nucleic acids by bleomycin. Chem Rev 98:1153–1169
Burger RM, Peisach J, Horwitz SB (1982) Effect of O2 on the reactions of activated bleomycin. J Biol Chem 257:3372–3375
Chen CB, Sigman DS (1988) Sequence-specific scission of RNA by 1,10-phenanthrolinecopper linked to deoxyoligonucleotides. J Am Chem Soc 110:6570–6572
D’Andrea AD, Haseltine WA (1978) Sequence specific cleavage of DNA by the antitumor antibiotics neocarzinostatin and bleomycin. Proc Natl Acad Sci USA 75:3608–3612
Dizdaroglu M, Aruoma OI, Halliwell B (1990) Modification of bases in DNA by copper ion-l,10-phenanthroline complexes. Biochemistry 29:8447–8451
Francois J-C, Saison-Behmoaras T, Barbier C, Chassignol M, Thuong NT, Helene C (1989) Sequence-specific recognition and cleavage of duplex DNA via triple-helix formation by oligonucleotides covalently linked to a phenanthroline-copper chelate. Proc Natl Acad Sci USA 86:9702–9706
Frolova EI, Fedorova OS, Knorre DG (1993) Kinetic study of the addressed modification by hemin derivatives of oligonucleotides. Biochimie 75:5–11
Gajewski E, Aruoma OI, Dizdaroglu M, Halliwell B (1991) Bleomycin-dependent damage to the bases in DNA is a minor side reaction. Biochemistry 30:2444–2448
Giloni L, Takeshita M, Johnson F, Iden C, Grollman AP (1981) Bleomycin-induced strandscission of DNA. Mechanism of deoxyribose cleavage. J Biol Chem 256:8608–8615
Godovikova TS, Zarytova VF, Sergeyev DS (1991) Direct cleavage of a DNA fragment by bleomycin As-oligonucleotide derivative. Bioorg Khim 17:1193–1200
Hecht SM (1994) RNA degradation by bleomycin, a naturally occurring bioconjugate. Bioconjug Chem 5:513–526.
Hecht SM (2000) Bleomycin: new perspectives on the mechanism of action. J Nat Prod 63:158–168
Henichart JP, Bernier JL, Helbecque N, Houssin R (1985) Is the bithiazole moiety of bleomycin a classical intercalator? Nucleic Acids Res 13:6703–6717
Holmes CE, Hecht SM (1993) Fe-Bleomycin cleaves a transfer RNA precursor and its “transfer-DNA” analog at the same major site. J Biol Chem 268:25909–25913
Holmes SE, Carter BJ, Hecht SM (1993) Characterization of iron(II)-bleomycin-mediated RNA strand scission. Biochemistry 32:4293–4307.
Holmes SE, Abraham AT, Hecht SM, Florentz C, Giege R (1996) Fe-Bleomycin as a probe of RNA conformation. Nucleic Acids Res 24:3399–3406
Holmes SE, Duff RJ, van der Marel GA, van Boom J, Hecht SM (1997) On the chemistry of RNA degradation by Fe-bleomycin. Bioorg Med Chem 5:1235–1248.
Keck MV, Hecht SM (1995) Sequence-specific hydrolysis of yeast tRNA(Phe) mediated by metal-free bleomycin. Biochemistry 34:12029–12037
Knorre DG, Vlassov VV, Zarytova VF, Lebedev AV, Fedorova OS (1994) Design and targeted reactions of oligonucleotide derivatives. CRC Press, Boca Raton
Kuramoshi H, Takahashi K, Takita T, Umezawa H (1981) An active intermediate formed in the reaction of bleomycin-Fe(II) complex with oxygen. J Antibiot 34:576–582
Kutyavin IV, Podyminogin MA, Bazhina YN, Fedorova OS, Knorre DG, Levina AS, Mamaev SV, Zarytova VF (1988) N-(2-hydroxyethyl)phenazinium derivatives of oligonucleotides as effectors of the sequence-specific modification of nucleic acids with reactive oligonucleotide derivatives.FEBS Lett 238:35–38
Lin SB, Blake KR, Miller PS, Ts’o PO (1989) Use of EDTA derivatization to characterize interactions between oligodeoxyribonucleoside methylphosphonates and nucleic acids. Biochemistry 28:1054–1061
Lown JW, Sim S-K (1977) The mechanism of the bleomycin induced cleavage of DNA. Biochem Biophys Res Commun 77:1150–1157
Magliozzo RS, Peisach S, Ciriolo MR (1989) Transfer RNA is cleaved by activated bleomycin. Mol Pharmacol 35:428–432
Mir LM, Tounekti O, Orlowski S (1996) Bleomycin: revival of an old drug. Gen Pharmacol 27:745–748
Murugesan N, Xu C, Ehrenfeld GM, Sugiyama H, Kilkuskie RE, Rodriguez LO, Chang LH, Hecht SM (1985) Analysis of products formed during bleomycin-mediated DNA degradation. Biochemistry 24:5735–5744
Onishi T, Iwata H, Takagi Y (1975) Effects of reducing and oxidizing agents on the action of bleomycin. J Biochem 77:745–752
Otsuka M, Masuda T, Haupt A, Ohno M, Shiraki T, Sugiura Y, Maeda K (1990) Mandesigned bleomycin with altered sequence specificity in DNA cleavage. J Am Chem Soc 112:838–845
Povirk LF (1979) Catalytic release of deoxyribonucleic acid by oxidation and reduction of an iron-bleomycin complex. Biochemistry 18:3989–3995
Rabow LE, McGall GH, Stubbe J, Kozarich JW (1990) Identification of the source of oxygen in the alkaline-labile product accompanying cytosine release during bleomycinmediated oxidative degradation of d(CGCGCG). J Am Chem Soc 112:3203–3208
Sam JW, Tang X-J, Peisach J (1994) Electrospray mass spectrometry of iron bleomycin: demonstration that activated bleomycin is a ferric peroxide complex. J Am Chem Soc 116:5250–5256
Sausville EA, Peisach J, Horwitz SB (1978) The effect of chelating agents and metal ions on the degradation of DNA by bleomycin. Biochemistry 17:2740–2746
Sergeyev DS, Zarytova VF (1996) Interaction of bleomycin and its oligonucleotide derivatives with nucleic acids. Russ Chem Rev 65:355–378
Sergeyev DS, Zarytova VF, Mamaev SV, Godovikova TS, Vlassov VV (1992) Sequences-pecific cleavage of single-stranded DNA by oligonucleotides conjugated to bleomycin. Antisense Res Dev 2:235–241
Sergeyev DS, Godovikova TS, Zarytova VF (1995a) Catalytic site-specific cleavage of a DNA-target by an oligonucleotide carrying bleomycin As. Nucleic Acids Res 23:4400–4406
Sergeyev DS, Godovikova TS, Zarytova VF (1995b) Cleavage of double-strand DNA by bleomycin derivatives of oligonucleotides forming a ternary complex. Bioorg Khim 21:188–196
Sergeyev DS, Denisov AY, Zarytova VF (1996) Structure elucidation of an oligonucleotide derivative of bleomycin As by l3C NMR. Bioorg Khim 22:54–57
Sersa G, Cufer T, Cemazar M, Rebersek M, Zvonimir R (2000) Electrochemotherapy with bleomycin in the treatment of hypernephroma metastasis: case report and literature review. Tumori 86:163–165
Smith JB, Vorobjev PE, Zarytova VF, Wickstrom E (1999) Site-specific cleavage of RNA by antisense DNA-bleomycin As conjugate. American Association for Cancer Research, Annual Meeting,1O-14 April, Philadelphia, PA, 133 pp
Strobel SA, Dervan PB (1990) Site-specific cleavage of a yeast chromosome by oligonucleotide-directed triple-helix formation. Science 249:73–75.
Stubbe J, Kozarich JW (1987) Mechanism of bleomycin-induced DNA degradation. Chem Rev 87:1107–1136
Sugiyama H, Kilkuskie RE, Chang LH, Ma LT, Hecht SM (1986) DNA strand scission by bleomycin: catalytic cleavage and strand selectivity. J Am Chem Soc 108:3852–3854
Takita T, Fujii A, Fukuoka T, Umezawa H (1973) Chemical cleavage of bleomycin to bleomycinic acid and synthesis of new bleomycins. J Antibiot 26:252–254
Umezawa H (1976) Structure and action of bleomycin. Prog Biochem Pharmacol 11:18–27
Umezawa H (1984) Antitumor antibiotics and low molecular weight immunomodifiers of microbial origin. Cancer Treat Rep 68:137–144
Umezawa H, Maeda K, Takeushi T, Okami Y (1966) New antibiotics, bleomycinsA and B. J Antibiot 19:200–209
Vlassov VV, Zarytova VF, Kutiavin IV, Mamaev SV, Podyminogin MA (1986) Complementary addressed modification and cleavage of a single stranded DNA fragment with alkylating oligonucleotide derivatives. Nucleic Acids Res 14:4065–4076
Vorobjev PE, Markushin YY, Sergeyev DS, Zarytova VF (1996) Effector oligonucleotides increase efficiency of site-specific cleavage of target DNA by bleomycin derivative of tetranucleotide. Bioorg Khim 22:111–116
Vorobjev PE, Yapryntseva OV, Zarytova VF (2000) Catalytic cleavage of DNA by bleomycin-oligonucleotide conjugates. Millennium Conference on Nucleic acid therapeutics, 8-11 January, Florida, p 40
Vorobjev PE, Pyshnaya IA, Wickstrom E, Zarytova VF (2002) Directed cleavage of RNA within an imperfect complementary complex by oligonucleotide-bleomycin As conjugates. Russ Chem Bull Int Ed 51:51:1187–1189
Vorobjev P, Yapryntseva O, Chaika O, Pyshnaya I, Wickstrom E, Zarytova V (2002) The design of bleomycin-oligonucleotide conjugates for efficient cleavage of nucleic acids. XV International round table “Nucleosides, nucleotides and nucleic acids”. Leuven, Belgium, September 10-14, P 203
Watanabe M, Takabe Y, Katsumata T, Terasima T, Umezawa H. (1973) Response in macromolecular syntheses of mouse L cell to bleomycin, with special reference to cellantibiotic interaction. J Antibiot 26:417–423
Worth LJ, Frank BL, Christner DA, Absalon MJ, Stubbe J, Kozarich JW (1993) Isotope effects on the cleavage of DNA by bleomycin: mechanism and modulation. Biochemistry 32:2601–2609
Wu JC, Kozarich JW, Stubbe (1983) The mechanism of free base formation from DNA by bleomycin. A proposal based on site specific tritium release from poly(dA-dU). J Biol Chem 258:4694–4697
Wu JC, Kozarich JW, Stubbe J (1985) Mechanism of bleomycin: evidence for a rate-determining 4′-hydrogen abstraction from poly(dA-dU) associated with the formation of both free base and base propenal. Biochemistry 24:7562–7568
Yamazaki ZI, Muller WEG, Zahn RK (1973) Action of bleomycin on programmed synthesis. Influence on enzymatic DNA, RNA and protein synthesis. Biochim Biophys Acta 308:412–421
Zarytova VF, Godovikova TS, Kutyavin IV, Khalimskaya LM (1987) Reactive oligonucleotide derivatives as affinity reagents and probes in molecular biology. In: Bruzik KS, Stec WJ (eds) Biophosphates and their analogues — synthesis, structure, metabolism and activity. Elsevier, Amsterdam, pp 149–164
Zarytova VF, Sergeyev DS, Godovikova TS (1993) Synthesis of bleomycin As oligonucleotide derivatives and site-specific cleavage of the DNA target. Bioconjugate Chem 4:189–193
Zarytova V, Ivanova E, Venyaminova A (1998) Design of functional diversity in oligonucleotides via zwitter-ionic derivatives of deprotected oligonucleotides. Nucleosides Nucleotides 17:649–662
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Vorobjev, P.E., Zarytova, V.F. (2004). Bleomycin-Oligonucleotide Conjugates as Site-Specific Nucleases. In: Zenkova, M.A. (eds) Artificial Nucleases. Nucleic Acids and Molecular Biology, vol 13. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18510-6_15
Download citation
DOI: https://doi.org/10.1007/978-3-642-18510-6_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62139-0
Online ISBN: 978-3-642-18510-6
eBook Packages: Springer Book Archive